Targeting mTOR in HIV-Negative Classic Kaposi's Sarcoma

Authors:

Abstract
A 66-year old female with HIV-negative classic Kaposi's sarcoma responded to mTOR targeting by rapamycin. The response was well documented by PET-CT. This case provides supporting evidence that the mTOR pathway may be important in the tumorigenesis of KS and that rapamycin may have activity in this disease.

This publication has 24 references indexed in Scilit: